The research indicates that S100A4 may play a role in regulating EMT or cancer stem cell properties in OC, thereby facilitating tumor progression via the miR-296/S100A4 (55) and S100A4/NMIIA/p53 (15) pathways. This evidence concerns the gene TP53 and neoplasm.